Advaite, an innovative biotechnology company, announced that it’s received CE Mark approval for its rapid IgG antibody test. To the COVID-19 virus called RapCov, which may help contain the spread of coronavirus infection.
The CE Mark will help strengthen the protection of European health from biological threats by facilitating the supply and use of medical countermeasures, including the Advaite RapCov rapid antibody test for COVID-19, which is important during health emergencies. Advaite is committed to bringing its COVID-19 Rapid Test Systems to the worldwide market. along side OBELIS SA as its authorized representative, Advaite Inc. will immediately begin work aimed toward expanding its activities and advertising.
“We believe the COVID-19 Advaite RapCov Rapid Test can provide unique benefits in containing the spread of infection. it’s simple to use and may give accurate results when analyzing a drop of blood from a finger with the detection of IgG antibodies to the virus COVID-19 in only quarter-hour – said CEO Advaite Kartik Musunuri ( Karthik Musunuri ). “In addition, this test system doesn’t require sending blood samples to the laboratory, which makes it a perfect solution for mass screening of the population.”
Also read :